Blockade of Kv1.3 potassium channel inhibits CD8+ T cell‐mediated neuroinflammation via PD‐1/Blimp‐1 signaling
Kv1.3 potassium channel is considered as a target for the treatment of autoimmune diseases such as multiple sclerosis (MS), since Kv1.3 blockade suppresses memory T cell activation including cytotoxic CD8+ T cells. However, the underlying signaling pathway related to autoimmune CD8+ T cell inhibitio...
Saved in:
Published in | The FASEB journal Vol. 34; no. 11; pp. 15492 - 15503 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Kv1.3 potassium channel is considered as a target for the treatment of autoimmune diseases such as multiple sclerosis (MS), since Kv1.3 blockade suppresses memory T cell activation including cytotoxic CD8+ T cells. However, the underlying signaling pathway related to autoimmune CD8+ T cell inhibition by Kv1.3 channel in neuroinflammatory diseases remains unclear. We found that ImK, a selective Kv1.3 blocker, reduced auto‐reactive CD8+ T cell infiltration in the spinal cords of experimental autoimmune encephalomyelitis (EAE) rats, an animal model of MS. ImK suppressed transcriptional factor Blimp‐1 expression and reduced the cytotoxicity of CD8+ T cells on neuronal cells. Furthermore, ImK upregulated co‐inhibitory molecule PD‐1 to inhibit B lymphocyte‐induced maturation protein (Blimp‐1) in an IL‐2 independent way. In addition, PD‐1 inhibitor impaired the suppression of ImK on CD8+ T cells and accelerated EAE progression. Our study demonstrated a novel regulatory mechanism of Kv1.3 blockade on modulating CD8+ T cell differentiation through PD‐1/Blimp‐1 signaling. This work expands the understanding of Kv1.3 channel for modulating neuroinflammation. |
---|---|
ISSN: | 0892-6638 1530-6860 |
DOI: | 10.1096/fj.202000861RR |